Clinical Trial of Endoscopically Guided Injection of Exparel (Bupivacaine) for the Treatment of Craniofacial Pain | MicrobiomeTrials← Back to trialsNCT04930887
Clinical Trial of Endoscopically Guided Injection of Exparel (Bupivacaine) for the Treatment of Craniofacial Pain
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2023-02-01Est. Completion: 2028-06
Enrollment target: 15 participants Locations- Peter H Hwang, Stanford, California, United States
Other microbiome trials you might be interested in
Analgesics, OpioidAcute PainTooth ExtractionAdolescentAcetaminophenIbuprofen
The goal of this clinical trial is to test a three-item intervention in oral surgeons who remove teeth. The main questio…
Lexington, United StatesCompleted Jan 2028
Graft Versus Host Disease
Background:
This study follows people who have had, or will soon have, a transplant using stem cells from another perso…
Bethesda, United StatesCompleted May 22, 2026
Intractable PainPalliative Care
This study will examine the safety of giving the experimental drug, resiniferatoxin (RTX), to treat severe pain in patie…
Bethesda, United StatesEst. completion Feb 7, 2027